website: 86th General Session & Exhibition of the IADR

ABSTRACT: 2646  

Rescue from Inflammatory Destruction in Experimental Colitis by Osteopontin Administration

A. PAES BATISTA DA SILVA1, A. KOH1, R. ELLEN1, H.A. GOLDBERG2, J. SODEK1, and R. ZOHAR1, 1University of Toronto, Canada, 2University of Western Ontario, London, Canada

Background: Osteopontin (OPN) is a matricellular cytokine present in most tissues and body fluids that is required for proper immune responses. Our studies using an experimental acute colitis model in the OPN-null (-/-) mouse found exacerbated tissue destruction and reduced repair in comparison to wild-type (WT) controls. Destruction of gut tissues was associated with increased neutrophils activity, reduced cell survival, and reduced secretion of inflammatory cytokines such as TNF-á and TGF-â1. Since OPN is normally present in milk, we hypothesize that dairy derived OPN may have a role in protecting the intestines from the adverse effects of inflammatory colitis. Objective: To analyze the ability of purified milk OPN dissolved in drinking water to subdue aggravated inflammation in the dextran sulfate sodium (DSS) colitis model. Methods: Purified bovine milk OPN dissolved in the drinking water in either physiological (HD) or 10-fold lower (LD) concentration was given to mice 24 hours prior to administration of the DSS to induce colitis. Clinical parameters and neutrophil functions were analyzed as previously reported ( J Cell Physiol 208:629, 2006). Results: HD-OPN significantly reduced disease activity indices (DAI) in DSS WT and OPN-/- mice. HD-treated DSS WT exhibited 37% less weight loss, reduced colon shortening, spleen enlargements, improved blood RBC counts and reduced gut neutrophil activity as shown by myeloperoxidase activity (P<0.05). Similar effects were found for DSS OPN-/- mice treated with HD-OPN but to a lesser degree than those found for WT. Conclusions: Physiological concentrations of dairy OPN dissolved in drinking water can improve the host response to DSS acute colitis.

Supported by grants ITM-83267 and 300360 from the Canadian Institutes of Health Research (CIHR) and the Dairy Farmers Foundation of Canada (JS, RZ, HG), and CIHR training fellowship STP-53877 and Harron Scholarship (APBS).

Back to Top